Sign Up Today and Learn More About Zocdoc Stock
Invest in or calculate the value of your shares in Zocdoc or other pre-IPO companies through EquityZen's platform.
Zocdoc Stock (ZOCD)
Zocdoc is a digital marketplace company that connects healthcare patients and doctors.
Zocdoc is an online network for patients to find and book appointments with doctors. Patients use Zocdoc to find in-network neighborhood doctors, instantly book appointments online, see what other real patients have to say, get reminders for upcoming appointments and preventive checkups, fill out their paperwork online, and more. Zocdocâs online marketplace aims to deliver an accessible and simple experience. Zocdoc is free for patients and available across the United States via Zocdoc.com or the Zocdoc app for iPhone and Android.
About Zocdoc Stock
Founded
2007
Total Funding
351M
Industries
Software, Health Care, Mobile
Zocdoc is a technology company that provides a better healthcare experience for millions of patients every month. Its online marketplace delivers the accessible, seamless, and simple experience patients expect and deserve. Zocdoc was founded in 2007 and is headquartered in New York.
Zocdoc Press Mentions
Stay in the know about the latest news on Zocdoc
Zocdoc CEO: âDr. Google is going to be replaced by Dr. AIâ
theverge ⢠Oct 20, 2025
Blue Shield of California Launches New Digital Tool for Medication Transparency
medcitynews ⢠Aug 11, 2025
60+ Companies Join CMSâ New Initiative for Data Interoperability & Patient-Facing Apps
medcitynews ⢠Aug 02, 2025
Apple, Google, and Others Join U.S. Push to End Paperwork in Healthcare
macobserver ⢠Jul 31, 2025
Apple joins White House push that promises to revamp digital healthcare
9to5mac ⢠Jul 31, 2025
Investors in Zocdoc
Discover investors in Zocdoc stock and explore their portfolio companies
Zocdoc Management
Leadership team at Zocdoc
CEO & Co-Founder
Oliver Kharraz
Chief AI Officer & Co-Founder
Nick Ganju
Join now and verify your accreditation status to gain access to:
- Zocdoc Current Valuation
- Zocdoc Stock Price
- Zocdoc Management
- Available deals in Zocdoc and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Zocdoc Cap Table and Funding History by Share Class and Liquidity Preferences
- Zocdoc Revenue and Financials
- Zocdoc Highlights
- Zocdoc Business Model
- Zocdoc Risk Factors
- Zocdoc Research Report from SACRA Research
Zocdoc Key Facts
- Strategic Expansion with Major Health Plans: Zocdoc is solidifying its position as a trusted partner for large healthcare payers. In June 2025, the company announced a partnership with Blue Shield of California to integrate its service, simplifying the appointment scheduling experience for Blue Shield members. This type of large-scale payer integration is a critical strategic initiative that broadens Zocdoc's market reach, validates its service quality, and directly addresses the core consumer pain point of finding in-network care.
- Focus on Patient Experience and Differentiation: The company is enhancing its competitive advantage by focusing on quality and transparency. In July 2025, Zocdoc launched its Patient Choice program, which highlights providers who consistently deliver superior patient experiences with a clear "mark of excellence" in search results. This initiative is designed to increase patient confidence, a best practice proven in leading marketplaces across other industries, and provides a new tool for top-performing providers to attract customers.
- Market Dominance and Extensive Network Reach: ZocDoc appears to have a strong position in the healthcare marketplace, stating that millions of people visit Zocdoc each month to search for healthcare providers and book appointments. The company reports that it has over 100,000 providers across 200 specialties on its platform and takes over 20,000 insurance plans.
- Complex Regulatory Environment: Zocdoc has faced significant regulatory ambiguity, especially regarding charging providers fees for patient bookings under statutes that predate the internet. Navigating these outdated healthcare regulations remains a challenge and requires continuous effort, creating operational uncertainty and potential compliance risks.
- Shifting Healthcare Payment Models: The rise of consumer-driven healthcare and cash-pay models challenges Zocdoc to adapt its platform and provider relationships. Patients increasingly seek transparent, upfront pricing, and out-of-network careâtrends that require flexibility but also introduce complexity in aligning providers and consumers efficiently.
- Uncertainty Over Financial Health: Zocdoc hasn't raised new funding since its $150 million growth financing round from Francisco Partners in 2021. While this could imply the company is profitable and stable, Zocdoc hasn't disclosed revenue figures since 2020. Zocdoc has previously experienced a high burn rate while its revenue flat-lined in 2015 and the full financial health of the business is unclear.
Trading Zocdoc Stock
How to invest in Zocdoc stock?
Accredited investors can buy pre-IPO stock in companies like Zocdoc through EquityZen funds. These investments are made available by existing Zocdoc shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event â house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Zocdoc stock?
Shareholders can sell their Zocdoc stock through EquityZen's private company marketplace. EquityZen's network includes over 400K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 49K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
